Satomi Shinonome

CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory

Yujiro Kidani, Wataru Nogami, Yoshiaki Yasumizu et al. · Proceedings of the National Academy of Sciences · 2022 · 204 citations · Full text

Life Sciences, Immunology, Oncology +17

Design, synthesis, and binding mode prediction of 2-pyridone-based selective CB2 receptor agonists

Ken‐ichi Kusakabe, Yukio Tada, Yasuyoshi Iso et al. · Bioorganic & Medicinal Chemistry · 2013 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Distribution analysis of epertinib in brain metastasis of HER2-positive breast cancer by imaging mass spectrometry and prospect for antitumor activity

Yukari Tanaka, Michinari Hirata, Satomi Shinonome et al. · Scientific Reports · 2018 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells

Yoji Nagira, Morio Nagira, Ryohei Nagai et al. · Molecular Cancer Therapeutics · 2023 · 32 citations · Full text

Life Sciences, Immunology, Oncology +17

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 1: Discovery of CB2 receptor selective compounds

Hiroyuki Kai, Yasuhide Morioka, Takami Murashi et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10